This may be a pretty remedial question, but is the implication that solid organ transplant patients react differently to the vaccine because of immunosuppression?
This is the part I object most to, because it implies strongly that the results are incomparable because of new strains. This is not right, since J&J sequenced their US cases and they were the same strain that was prevalent in the US during the mRNA trials.
Nothing against going to get a safe and pretty darn effective vaccine. But there's this whole thing about media accuracy norms that drives me nuts.